login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock News
USA
-
Nasdaq
- NASDAQ:DAWN -
US23954D1090
-
Common Stock
8.48
USD
+0.23 (+2.79%)
Last: 12/17/2025, 12:01:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DAWN Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Day One Biopharmaceuticals, Inc.
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
a day ago - By: Day One Biopharmaceuticals, Inc.
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
23 days ago - By: Day One Biopharmaceuticals, Inc.
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
a month ago - By: Investor's Business Daily
- Mentions:
MRSN
Mersana Catapults 200% On Day One Bio's Surprise Buyout
a month ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
4 months ago - By: The Motley Fool
Day One (DAWN) Q2 Revenue Jumps 313%
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
a month ago - By: Zacks Investment Research
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 161.36%: Here's is How to Trade
a month ago - By: Stocktwits
- Mentions:
MRSN
Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’
a month ago - By: Benzinga
- Mentions:
MRSN
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout
a month ago - By: Stocktwits
- Mentions:
MRSN
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
a month ago - By: Zacks Investment Research
- Mentions:
DNTH
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
a month ago - By: Day One Biopharmaceuticals, Inc.
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
2 months ago - By: Zacks Investment Research
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?
2 months ago - By: Day One Biopharmaceuticals, Inc.
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
2 months ago - By: Day One Biopharmaceuticals, Inc.
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
4 months ago - By: Day One Biopharmaceuticals, Inc.
Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
4 months ago - By: Day One Biopharmaceuticals, Inc.
Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
5 months ago - By: Day One Biopharmaceuticals, Inc.
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
5 months ago - By: Day One Biopharmaceuticals, Inc.
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
6 months ago - By: Day One Biopharmaceuticals, Inc.
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
6 months ago - By: Day One Biopharmaceuticals, Inc.
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
7 months ago - By: Yahoo Finance
- Mentions:
DHI
CMG
Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now?
7 months ago - By: Yahoo Finance
- Mentions:
VZ
NVO
LYFT
DECK
...
Novo Nordisk A/S (NVO): A Bull Case Theory
7 months ago - By: Yahoo Finance
- Mentions:
RXRX
NVDA
PRTA
ROG
...
Why Recursion Pharmaceuticals Stock Plummeted 24% This Week
7 months ago - By: Yahoo Finance
- Mentions:
NVDA
GS
FCX
SCCO
...
NVIDIA Corporation (NVDA): Among Chris Rokos’ Stock Picks with Huge Upside Potential
Please enable JavaScript to continue using this application.